Lv31
236 积分 2022-04-02 加入
Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications
2小时前
待确认
Investigation of Infection Risk Associated with Janus Kinase Inhibitors: A Pharmacovigilance Analysis Using the Food and Drug Administration's Adverse Event Reporting System Database
2小时前
已完结
Small molecule drug discovery targeting the JAK-STAT pathway
6天前
已完结
Correlation of systemic immune inflammation and serum uric acid with gout: based on NHANES
13天前
已完结
The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms
1个月前
已完结
Pathogenesis of rheumatoid arthritis: one year in review 2024
1个月前
已完结
Mass balance study of [14C]SHR0302, a selective and potent JAK1 inhibitor in humans
1个月前
已完结
Pharmacokinetic review of janus kinase inhibitors and its clinical implications for the management of rheumatoid arthritis
1个月前
已完结
Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders
1个月前
已完结
Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship
1个月前
已完结
皖公网安备34019202002308
